A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2589265
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being the accumulation factor) standard daily dosage is administered and thereafter continued at the standard daily dosage or at a daily dosage lower than the standard daily dosage.
Selon l'invention, des modulateurs ou agonistes du récepteur S1P sont administrés conformément à une posologie selon laquelle, au cours des 3 à 6 jours initiaux de traitement, la dose quotidienne est augmentée si bien qu'au total, la dose quotidienne normale multipliée par R (R étant le facteur d'accumulation) est administrée, et le traitement poursuivi ensuite à ladite dose quotidienne normale ou à une dose quotidienne inférieure à la dose quotidienne normale.
Appel-Dingemanse Silke
Kovarik John M.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Dosage regimen of an s1p receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage regimen of an s1p receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage regimen of an s1p receptor agonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761839